Unknown

Dataset Information

0

Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.


ABSTRACT:

Rationale

Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associated with phenotypic resistance but are poorly detected by Sanger sequencing or commercial molecular diagnostic assays.

Objectives

To determine the role of targeted next-generation sequencing in resolving these minor variant subpopulations.

Methods

We used single molecule overlapping reads (SMOR), a targeted next-generation sequencing approach that dramatically reduces sequencing error, to analyze primary cultured isolates phenotypically resistant to rifampin, fluoroquinolones, or aminoglycosides, but for which Sanger sequencing found no resistance-associated variants (RAVs) within respective resistance-determining regions (study group). Isolates also underwent single-colony selection on antibiotic-containing agar, blinded to sequencing results. As a positive control, isolates with multiple colocalizing chromatogram peaks were also analyzed (control group).

Measurements and main results

Among 61 primary culture isolates (25 study group and 36 control group), SMOR described 66 (49%) and 45 (33%) of 135 total heteroresistant RAVs at frequencies less than 5% and less than 1% of the total mycobacterial population, respectively. In the study group, SMOR detected minor resistant variant subpopulations in 80% (n = 20/25) of isolates with no Sanger-identified RAVs (median subpopulation size, 1.0%; interquartile range, 0.2-3.9%). Single-colony selection on drug-containing media corroborated SMOR results for 90% (n = 18/20) of RAV-containing specimens, and the absence of RAVs in 60% (n = 3/5) of isolates. Overall, Sanger sequencing was concordant with SMOR for 77% (n = 53/69) of macroheteroresistant (5-95% total population), but only 5% of microheteroresistant (<5%) subpopulations (n = 3/66) across both groups.

Conclusions

Cryptic minor variant mycobacterial subpopulations exist below the resolving capability of current drug susceptibility testing methodologies, and may explain an important proportion of false-negative resistance determinations.

SUBMITTER: Metcalfe JZ 

PROVIDER: S-EPMC5694839 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.

Metcalfe John Z JZ   Streicher Elizabeth E   Theron Grant G   Colman Rebecca E RE   Allender Christopher C   Lemmer Darrin D   Warren Rob R   Engelthaler David M DM  

American journal of respiratory and critical care medicine 20171101 9


<h4>Rationale</h4>Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associated with phenotypic resistance but are poorly detected by Sanger sequencing or commercial molecular diagnostic assays.<h4>Objectives</h4>To determine the role of targeted next-generation sequencing in resolving these minor variant subpopulations.<h4>Methods</h4>We used single molecule overlapping reads (SMOR), a targeted next-generation sequencing approach that dramatically reduces sequencing error,  ...[more]

Similar Datasets

| S-EPMC9742156 | biostudies-literature
| S-EPMC7738170 | biostudies-literature
| S-EPMC90060 | biostudies-literature
2019-03-25 | PXD009676 | Pride
| S-EPMC4325781 | biostudies-literature
| S-EPMC1186028 | biostudies-literature
| S-EPMC11750862 | biostudies-literature
| S-EPMC3441462 | biostudies-literature
| S-EPMC6581888 | biostudies-literature